NASDAQ:CDMO Avid Bioservices (CDMO) Stock Price, News & Analysis $7.42 -0.28 (-3.64%) (As of 07/5/2024 ET) Add Compare Share Share Today's Range$7.38▼$7.7250-Day Range$6.70▼$9.2852-Week Range$4.07▼$14.27Volume827,699 shsAverage Volume1.02 million shsMarket Capitalization$471.76 millionP/E RatioN/ADividend YieldN/APrice Target$12.67 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Avid Bioservices alerts: Email Address Avid Bioservices MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.75 Rating ScoreUpside/Downside70.7% Upside$12.67 Price TargetShort InterestBearish23.72% of Shares Sold ShortDividend StrengthN/ASustainability-0.96Upright™ Environmental ScoreNews Sentiment0.07Based on 8 Articles This WeekInsider TradingSelling Shares$127,546 Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.32 out of 5 starsMedical Sector265th out of 879 stocksPharmaceutical Preparations Industry120th out of 417 stocks 3.4 Analyst's Opinion Consensus RatingAvid Bioservices has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageAvid Bioservices has only been the subject of 1 research reports in the past 90 days.Read more about Avid Bioservices' stock forecast and price target. Previous Next 0.0 Short Interest Percentage of Shares Shorted23.72% of the outstanding shares of Avid Bioservices have been sold short.Short Interest Ratio / Days to CoverAvid Bioservices has a short interest ratio ("days to cover") of 14.6, which indicates bearish sentiment.Change versus previous monthShort interest in Avid Bioservices has recently increased by 31.02%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAvid Bioservices does not currently pay a dividend.Dividend GrowthAvid Bioservices does not have a long track record of dividend growth. Previous Next 4.5 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreAvid Bioservices has received a 68.99% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Biopharmaceuticals", "Clinical research services", and "Process engineering services for the pharmaceutical industry" products. See details.Environmental SustainabilityThe Environmental Impact score for Avid Bioservices is -0.96. Previous Next 2.3 News and Social Media Coverage News SentimentAvid Bioservices has a news sentiment score of 0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Avid Bioservices this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for CDMO on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows2 people have added Avid Bioservices to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Avid Bioservices insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $127,546.00 in company stock.Percentage Held by InsidersOnly 2.39% of the stock of Avid Bioservices is held by insiders.Percentage Held by Institutions97.16% of the stock of Avid Bioservices is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Avid Bioservices' insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Avid Bioservices is -27.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Avid Bioservices is -27.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAvid Bioservices has a P/B Ratio of 2.46. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Avid Bioservices' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 Media[Urgent] Hedge Funds Expect Major Crypto MovesIn the year following Bitcoin’s last Halving event, that happened in May of 2020… Bitcoin shot up over 550%. But that’s not all… Click here to register now. About Avid Bioservices Stock (NASDAQ:CDMO)Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries. The company offers various services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.Read More CDMO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CDMO Stock News HeadlinesJuly 5 at 4:38 AM | americanbankingnews.comAvid Bioservices (NASDAQ:CDMO) Rating Reiterated by Royal Bank of CanadaJuly 2, 2024 | globenewswire.comAvid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024July 7, 2024 | Crypto 101 Media (Ad)[Urgent] Hedge Funds Expect Major Crypto MovesIn the year following Bitcoin’s last Halving event, that happened in May of 2020… Bitcoin shot up over 550%. But that’s not all… July 1, 2024 | globenewswire.comAvid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024May 23, 2024 | globenewswire.comAvid Bioservices Earns Committed Badge from EcoVadis for Sustainability PerformanceMay 16, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMOMay 7, 2024 | globenewswire.comAvid Bioservices to Participate at Upcoming Investor ConferencesMay 6, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMOJuly 7, 2024 | Crypto 101 Media (Ad)[Urgent] Hedge Funds Expect Major Crypto MovesIn the year following Bitcoin’s last Halving event, that happened in May of 2020… Bitcoin shot up over 550%. But that’s not all… May 2, 2024 | finance.yahoo.comSmall Molecule CMO/CDMO Market Outlook 2024-2033: Rising Focus on Personalized Medicine and Niche Therapies WorldwideApril 30, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: AIM ImmunoTech (AIM) and Avid Bioservices (CDMO)April 30, 2024 | finance.yahoo.comQ3 2024 Avid Bioservices Inc Earnings CallApril 24, 2024 | globenewswire.comAvid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024April 21, 2024 | seekingalpha.comLaughing Water Capital - Avid Bioservices: A Few Years Away From Large, Relatively Sticky FCFApril 12, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMOApril 4, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMOMarch 27, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMOMarch 20, 2024 | globenewswire.comAvid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-QSee More Headlines Receive CDMO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avid Bioservices and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/24/2024Today7/07/2024Next Earnings (Estimated)9/05/2024Fiscal Year End4/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:CDMO CUSIPN/A CIK704562 Webwww.avidbio.com Phone(714) 508-6100Fax714-838-5817Employees365Year FoundedN/APrice Target and Rating Average Stock Price Target$12.67 High Stock Price Target$16.00 Low Stock Price Target$8.00 Potential Upside/Downside+70.7%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.27) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$260,000.00 Net Margins-100.57% Pretax Margin-15.47% Return on Equity-11.27% Return on Assets-4.61% Debt Debt-to-Equity Ratio0.04 Current Ratio0.46 Quick Ratio0.31 Sales & Book Value Annual Sales$139.91 million Price / Sales3.37 Cash Flow$0.15 per share Price / Cash Flow48.11 Book Value$3.02 per share Price / Book2.46Miscellaneous Outstanding Shares63,580,000Free Float61,963,000Market Cap$471.76 million OptionableOptionable Beta1.36 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Nicholas Stewart Green B.Sc. (Age 59)MBA, President, CEO & Director Comp: $1.35MMr. Daniel R. Hart (Age 51)Chief Financial Officer Comp: $719.75kMr. Richard Richieri (Age 59)Chief Operations Officer Comp: $561.68kMr. Mark R. Ziebell J.D. (Age 60)VP, General Counsel & Corporate Secretary Comp: $647.1kMr. Matthew Kwietniak (Age 55)Chief Commercial Officer Comp: $553.59kMs. Oksana LukashVice President of PeopleMore ExecutivesKey CompetitorsUrovant SciencesNASDAQ:UROVRigel PharmaceuticalsNASDAQ:RIGLG1 TherapeuticsNASDAQ:GTHXArvinasNASDAQ:ARVNGalapagosNASDAQ:GLPGView All CompetitorsInsiders & InstitutionsAWM Investment Company Inc.Sold 237,848 shares on 5/16/2024Ownership: 1.093%Kennedy Capital Management LLCBought 255,201 shares on 5/16/2024Ownership: 0.941%Kent Lake Capital LLCBought 280,504 shares on 5/16/2024Ownership: 0.442%California State Teachers Retirement SystemSold 3,333 shares on 5/16/2024Ownership: 0.099%Price T Rowe Associates Inc. MDBought 1,649 shares on 5/15/2024Ownership: 0.048%View All Insider TransactionsView All Institutional Transactions CDMO Stock Analysis - Frequently Asked Questions How have CDMO shares performed this year? Avid Bioservices' stock was trading at $6.50 at the beginning of 2024. Since then, CDMO shares have increased by 14.2% and is now trading at $7.42. View the best growth stocks for 2024 here. How were Avid Bioservices' earnings last quarter? Avid Bioservices, Inc. (NASDAQ:CDMO) issued its earnings results on Wednesday, April, 24th. The biopharmaceutical company reported ($0.08) earnings per share for the quarter, missing analysts' consensus estimates of ($0.02) by $0.06. The biopharmaceutical company earned $33.82 million during the quarter, compared to analyst estimates of $33.80 million. Avid Bioservices had a negative net margin of 100.57% and a negative trailing twelve-month return on equity of 11.27%. When did Avid Bioservices' stock split? Avid Bioservices shares reverse split on Monday, July 10th 2017. The 1-7 reverse split was announced on Friday, July 7th 2017. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 7th 2017. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split. What is Roger Lias' approval rating as Avid Bioservices' CEO? 5 employees have rated Avid Bioservices Chief Executive Officer Roger Lias on Glassdoor.com. Roger Lias has an approval rating of 49% among the company's employees. This puts Roger Lias in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 63.0% of employees surveyed would recommend working at Avid Bioservices to a friend. How do I buy shares of Avid Bioservices? Shares of CDMO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Avid Bioservices own? Based on aggregate information from My MarketBeat watchlists, some other companies that Avid Bioservices investors own include Array Technologies (ARRY), Anavex Life Sciences (AVXL), Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), Dynavax Technologies (DVAX), Micron Technology (MU) and QUALCOMM (QCOM). This page (NASDAQ:CDMO) was last updated on 7/7/2024 by MarketBeat.com Staff From Our Partners270x more lucrative than NVIDIA???If you've missed out on NVIDIA's recent 1,600% run... Don't worry. Because there's one AI stock that cou...Behind the Markets | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredBiden to drop out; finish out his term?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredObama’s DNC coupAs we approach the Democratic National Convention in August... many sense a Biden swap-out is looming. In f...Stansberry Research | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avid Bioservices, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avid Bioservices With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDMO Stock Alerts